Opus Genetics (IRD) Assets Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Opus Genetics | 357.99 Mn | 298.03 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 38.66% |
| Dec 31, 2025 | 36.30% |
| Sep 30, 2025 | -10.56% |
| Jun 30, 2025 | -13.76% |
| Mar 31, 2025 | -7.09% |
| Dec 31, 2024 | -31.67% |
| Sep 30, 2024 | -25.47% |
| Jun 30, 2024 | 3.15% |
| Mar 31, 2024 | 14.18% |
| Dec 31, 2023 | 10.12% |
| Sep 30, 2023 | 271.99% |
| Jun 30, 2023 | 142.83% |
| Mar 31, 2023 | 121.65% |
| Dec 31, 2022 | 87.87% |
| Sep 30, 2022 | -37.22% |
| Jun 30, 2022 | -29.12% |
| Mar 31, 2022 | 68.93% |
| Dec 31, 2021 | 47.48% |
| Sep 30, 2021 | 162.68% |
| Jun 30, 2021 | 146.38% |
| Mar 31, 2021 | 4.96% |
| Dec 31, 2020 | 891.14% |
| Sep 30, 2020 | -41.03% |
| Jun 30, 2020 | -42.02% |
| Mar 31, 2020 | -40.53% |
| Dec 31, 2019 | -88.88% |
| Sep 30, 2019 | 7.97% |
| Jun 30, 2019 | -3.06% |
| Mar 31, 2019 | -13.87% |
| Dec 31, 2018 | -43.29% |
| Sep 30, 2018 | -43.58% |
| Jun 30, 2018 | -35.09% |
| Mar 31, 2018 | 15.18% |
| Dec 31, 2017 | 34.43% |
| Sep 30, 2017 | 8.13% |
| Jun 30, 2017 | 36.84% |
| Mar 31, 2017 | -23.38% |
| Dec 31, 2016 | -15.16% |
| Sep 30, 2016 | -1.44% |
| Jun 30, 2016 | -24.99% |
| Mar 31, 2016 | -16.16% |
| Dec 31, 2015 | -26.03% |
| Sep 30, 2015 | -36.70% |
| Jun 30, 2015 | -30.26% |
| Mar 31, 2015 | -25.88% |
| Dec 31, 2014 | 71.47% |
| Sep 30, 2014 | 126.79% |
| Jun 30, 2014 | 254.38% |
| Mar 31, 2014 | 207.96% |
| Dec 31, 2013 | 31.08% |
| Sep 30, 2013 | 101.49% |
| Jun 30, 2013 | 13.48% |
| Mar 31, 2013 | 14.04% |
| Dec 31, 2012 | 8.98% |
| Sep 30, 2012 | -57.31% |
| Jun 30, 2012 | -55.39% |
| Dec 31, 2011 | -15.58% |